C. Rice

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

Michael A. Pfaller, S. A. Messer, L. Boyken et al. · Diagnostic Microbiology and Infectious Disease · 2004 · 235 citations

Antifungal Agent, Pathogenic Microbiology, Antifungal Agents +11

Global Trends in the Antifungal Susceptibility of <i>Cryptococcus neoformans</i> (1990 to 2004)

Michael A. Pfaller, S. A. Messer, L. Boyken et al. · Journal of Clinical Microbiology · 2005 · 204 citations · Full text

Pathogenic Microbiology, Clinical Laboratory Standards, Clinical Mycology +16

Antimicrobial Resistance among <i>Streptococcus pneumoniae</i> in the United States: Have We Begun to Turn the Corner on Resistance to Certain Antimicrobial Classes?

Gary V. Doern, Sandra S. Richter, Ashley L. Miller et al. · Clinical Infectious Diseases · 2005 · 198 citations · Full text

Macrolide-Resistant Streptococcus pyogenes in the United States, 2002-2003

Sandra S. Richter, Kristopher P. Heilmann, Susan E. Beekmann et al. · Clinical Infectious Diseases · 2005 · 149 citations

Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant <i>Candida</i>

Michael A. Pfaller, S. A. Messer, L. Boyken et al. · Journal of Clinical Microbiology · 2003 · 109 citations · Full text